These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37441164)

  • 1. Targeted metabolomics analysis of nucleosides and the identification of biomarkers for colorectal adenomas and colorectal cancer.
    Zheng W; Wang M; Chai X; Pan F; Xu M; Wang Y; Lan L; Hu F; Zhang Z; Chen Z
    Front Mol Biosci; 2023; 10():1163089. PubMed ID: 37441164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of dimethylated nucleosides in serum from colorectal cancer patients by hydrophilic interaction liquid chromatography-tandem mass spectrometry.
    Cao X; Wang M; Huang Y; Zhang M; Zheng F; Zhang G; Su J; Yuan Y; Guo C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jan; 1232():123973. PubMed ID: 38142502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass Spectrometry-Based Targeted Serum Monomethylated Ribonucleosides Profiling for Early Detection of Breast Cancer.
    Fang Z; Hu Y; Chen J; Xu K; Wang K; Zheng S; Guo C
    Front Mol Biosci; 2021; 8():741603. PubMed ID: 34513933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Analysis of Methylated Adenosine Modifications Revealed Increased Levels of
    Hu Y; Fang Z; Mu J; Huang Y; Zheng S; Yuan Y; Guo C
    Front Cell Dev Biol; 2021; 9():694673. PubMed ID: 34381776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Determination of Methylated Nucleosides by HILIC-MS/MS Revealed Their Alterations in Urine from Breast Cancer Patients.
    Fang Z; Hu Y; Hong X; Zhang X; Pan T; Pan C; Zheng S; Guo C
    Metabolites; 2022 Oct; 12(10):. PubMed ID: 36295875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring urinary modified nucleosides as biomarkers for diabetic retinopathy: Development and validation of a ultra performance liquid chromatography-tandem mass spectrometry method.
    Yao C; Lv D; Zhou X; Fu P; Sun W; Chen J; Lin H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jan; 1232():123968. PubMed ID: 38150972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum metabolite signatures in normal individuals and patients with colorectal adenoma or colorectal cancer using UPLC-MS/MS method.
    Guo J; Pan Y; Chen J; Jin P; Tang S; Wang H; Su H; Wang Q; Chen C; Xiong F; Liu K; Li Y; Su M; Tang T; He Y; Sheng J
    J Proteomics; 2023 Jan; 270():104741. PubMed ID: 36174955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel malic acid-enhanced method for the analysis of 5-methyl-2'-deoxycytidine, 5-hydroxymethyl-2'-deoxycytidine, 5-methylcytidine and 5-hydroxymethylcytidine in human urine using hydrophilic interaction liquid chromatography-tandem mass spectrometry.
    Guo C; Xie C; Chen Q; Cao X; Guo M; Zheng S; Wang Y
    Anal Chim Acta; 2018 Nov; 1034():110-118. PubMed ID: 30193624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.
    Komor MA; Bosch LJ; Coupé VM; Rausch C; Pham TV; Piersma SR; Mongera S; Mulder CJ; Dekker E; Kuipers EJ; van de Wiel MA; Carvalho B; Fijneman RJ; Jimenez CR; Meijer GA; de Wit M
    J Pathol; 2020 Mar; 250(3):288-298. PubMed ID: 31784980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HILIC-MS/MS for the Determination of Methylated Adenine Nucleosides in Human Urine.
    Guo C; Hu Y; Cao X; Wang Y
    Anal Chem; 2021 Dec; 93(51):17060-17068. PubMed ID: 34902250
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening and diagnosis of colorectal cancer and advanced adenoma by Bionic Glycome method and machine learning.
    Pan Y; Zhang L; Zhang R; Han J; Qin W; Gu Y; Sha J; Xu X; Feng Y; Ren Z; Dai J; Huang B; Ren S; Gu J
    Am J Cancer Res; 2021; 11(6):3002-3020. PubMed ID: 34249441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of adenosine and its modifications in urine and plasma from breast cancer patients by hydrophilic interaction liquid chromatography-tandem mass spectrometry.
    Zhang X; Hu Y; Hong X; Wang M; Fang Z; Cao X; Jiang K; Guo C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct; 1209():123428. PubMed ID: 36041348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted metabolomics: Liquid chromatography coupled to mass spectrometry method development and validation for the identification and quantitation of modified nucleosides as putative cancer biomarkers.
    Godoy AT; Eberlin MN; Simionato AVC
    Talanta; 2020 Apr; 210():120640. PubMed ID: 31987192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
    Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
    BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal Cancer Detection Using Targeted LC-MS Metabolic Profiling.
    Djukovic D; Zhang J; Raftery D
    Methods Mol Biol; 2018; 1765():229-240. PubMed ID: 29589312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
    Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
    World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of urinary methylated nucleosides of patients with coronary artery disease by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Li Y; Yu H; Zhao W; Xu X; Zhou J; Xu M; Gao W; Yuan G
    Rapid Commun Mass Spectrom; 2014 Oct; 28(19):2054-8. PubMed ID: 25156594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.